149 related articles for article (PubMed ID: 28102933)
1. What if a tumor is significantly enlarged just before stereotactic body radiation therapy? A case report and review of the literature.
Chen HJ; Liang JA; Chen CY; Yu YH; Chien CR
Thorac Cancer; 2017 Mar; 8(2):118-120. PubMed ID: 28102933
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancer.
Mitera G; Swaminath A; Rudoler D; Seereeram C; Giuliani M; Leighl N; Gutierrez E; Dobrow MJ; Coyte PC; Yung T; Bezjak A; Hope AJ
J Oncol Pract; 2014 May; 10(3):e130-6. PubMed ID: 24643574
[TBL] [Abstract][Full Text] [Related]
3. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
[TBL] [Abstract][Full Text] [Related]
4. Comparison Between Stereotactic and Conventional Radiotherapy for Solitary Lung Tumor After Resection of Lung Cancer.
Takahashi S; Go T; Anada M; Kinoshita T; Nishide T; Yokomise H; Shibata T
Anticancer Res; 2019 Jun; 39(6):2957-2962. PubMed ID: 31177135
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
[TBL] [Abstract][Full Text] [Related]
6. Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy.
Zhang Z; Wodzak M; Belzile O; Zhou H; Sishc B; Yan H; Stojadinovic S; Mason RP; Brekken RA; Chopra R; Story MD; Timmerman R; Saha D
Radiat Res; 2016 Jun; 185(6):616-22. PubMed ID: 27223828
[TBL] [Abstract][Full Text] [Related]
7. Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.
Swaminath A; Wierzbicki M; Parpia S; Wright JR; Tsakiridis TK; Okawara GS; Kundapur V; Bujold A; Ahmed N; Hirmiz K; Kurien E; Filion E; Gabos Z; Faria S; Louie AV; Owen T; Wai E; Ramchandar K; Chan EK; Julian J; Cline K; Whelan TJ
Clin Lung Cancer; 2017 Mar; 18(2):250-254. PubMed ID: 27876603
[TBL] [Abstract][Full Text] [Related]
8. Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for Surveillance.
Spratt DE; Wu AJ; Adeseye V; Din SU; Shaikh F; Woo KM; Zhang Z; Foster A; Rosenzweig KE; Gewanter R; Huang J; Rimner A
Clin Lung Cancer; 2016 May; 17(3):177-183.e2. PubMed ID: 26602271
[TBL] [Abstract][Full Text] [Related]
9. Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG; Steuer CE; Owonikoko TK; Ramalingam SS; Bradley JD; Curran WJ
J Thorac Oncol; 2017 Nov; 12(11):1687-1695. PubMed ID: 28919394
[TBL] [Abstract][Full Text] [Related]
10. Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.
Rosen LR; Fischer-Valuck BW; Katz SR; Durci M; Wu HT; Syh J; Syh J; Patel B
Tumori; 2014; 100(1):42-8. PubMed ID: 24675490
[TBL] [Abstract][Full Text] [Related]
11. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer.
Eriguchi T; Takeda A; Sanuki N; Nishimura S; Takagawa Y; Enomoto T; Saeki N; Yashiro K; Mizuno T; Aoki Y; Oku Y; Yokosuka T; Shigematsu N
J Radiat Res; 2016 Jun; 57(3):265-72. PubMed ID: 26983978
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
Bradley JD; El Naqa I; Drzymala RE; Trovo M; Jones G; Denning MD
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1146-50. PubMed ID: 19800181
[TBL] [Abstract][Full Text] [Related]
15. No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer.
Badellino S; Muzio JD; Schivazappa G; Guarneri A; Ragona R; Bartoncini S; Trino E; Filippi AR; Fonio P; Ricardi U
Br J Radiol; 2017 Oct; 90(1078):20170143. PubMed ID: 28749172
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Primer for Radiologists.
Febbo JA; Gaddikeri RS; Shah PN
Radiographics; 2018; 38(5):1312-1336. PubMed ID: 30074857
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
Sher DJ; Wee JO; Punglia RS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
[TBL] [Abstract][Full Text] [Related]
18. Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy.
Rico M; Martínez E; Pellejero S; Bermejo B; Navarrete P; Barrado M; Campo M; Mañeru F; Villafranca E; Aristu J
Clin Transl Oncol; 2016 Oct; 18(10):1011-8. PubMed ID: 26758718
[TBL] [Abstract][Full Text] [Related]
19. Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy.
Rossi MM; Peulen HM; Belderbos JS; Sonke JJ
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):835-43. PubMed ID: 27131084
[TBL] [Abstract][Full Text] [Related]
20. Inter-scan and inter-observer tumour volume delineation variability on cone beam computed tomography in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Hou Y; Lee S; Agrawal V; Romano J; Baldini EH; Chen AB; Kozono DE; Killoran JH; Wagar M; Hacker FL; Aerts HJ; Lewis JH; Mak RH
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):93-98. PubMed ID: 27709803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
